Serum pepsinogen I/II ratio is correlated with albuminuria in patients with type 2 diabetes

Endocrine Journal

Volumn 60, Issue 2, 2013, Pages 161-166

  Senmaru, Takafumi ^a   Fukui, Michiaki ^a   Kuroda, Masaaki ^b   Tanaka, Muhei ^a   Ushigome, Emi ^a   Sakabe, Kazumi ^a   Nakanishi, Naoko ^a   Mineoka, Yusuke ^a   Asano, Mai ^a   Yamazaki, Masahiro ^a   Hasegawa, Goji ^a   Nakamura, Naoto ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Yamashiro Public Hospital   (Japan)

Author keywords

Albuminuria; Nephropathy; Pepsinogen; Type 2 diabetes

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; HEMOGLOBIN A1C; LIPID; PEPSINOGEN I; PEPSINOGEN II; URIC ACID;

AGED; ALBUMINURIA; ARTICLE; BLOOD PRESSURE; BODY MASS; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; ENZYME BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HELICOBACTER INFECTION; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

AGED; ALBUMINURIA; ALGORITHMS; ANTIBODIES, BACTERIAL; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; JAPAN; KIDNEY; MALE; MIDDLE AGED; PEPSINOGEN A; PEPSINOGEN C; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84874597834     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ12-0244     Document Type: Article

References (21)

1. Fang J, Alderman MH (2000) Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 283: 2404-2410.
2. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, et al. (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24: 683-689.
3. Ohnishi M, Fukui M, Ishikawa T, Ohnishi N, Ishigami N, et al. (2008) Helicobacter pylori infection and arterial stiffness in patients with type 2 diabetes mellitus. Metabolism 57: 1760-1764.
4. Pietroiusti A, Giuliano M, Magrini A, Bergamaschi A, Galante A (2006) Cytotoxin-associated gene A strains of Helicobacter pylori represent a risk factor for the development of microalbuminuria in type 2 diabetes. Diabetes Care 29: 1399-1401.
5. Miki K, Morita M, Sasajima M, Hoshina R, Kanda E, et al. (2003) Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol 98: 735-739.
6. American Diabetes Association (2012) Diagnosis and classification of diabetes mellitus. Diabetes Care 35: S64-71.
7. Yasuda H, Sanada M, Kitada K, Terashima T, Kim H, et al. (2007) Rationale and usefulness of newly devised abbreviated diagnostic criteria and staging for diabetic polyneuropathy. Diabetes Res Clin Pract 77 Suppl 1:178-183.
8. Suzuki H, Masaoka T, Hosoda H, Ota T, Minegishi Y, et al. (2004) Helicobacter pylori infection modifies gastric and plasma ghrelin dynamics in Mongolian gerbils. Gut 53: 187-194.
9. Isomoto H, Nakazato M, Ueno H, Date Y, Nishi Y, et al. (2004) Low plasma ghrelin levels in patients with Helicobacter pylori-associated gastritis. Am J Med 117: 429-432.
10. Kawashima J, Ohno S, Sakurada T, Takabayashi H, Kudo M, et al. (2009) Circulating acylated ghrelin level decreases in accordance with the extent of atrophic gastritis. J Gastroenterol 44: 1046-1054.
11. Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, et al. (2001) Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120: 337-345.
12. Tschop M, Smiley DL, Heiman ML (2000) Ghrelin induces adiposity in rodents. Nature 407: 908-913.
13. Miki K, Ichinose M, Shimizu A, Huang SC, Oka H, et al. (1987) Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn 22: 133-141.
14. Kinoshita Y, Kawanami C, Kishi K, Nakata H, Seino Y, et al. (1997) Helicobacter pylori independent chronological change in gastric acid secretion in the Japanese. Gut 41: 452-458.
15. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, et al. (1994) Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 71: 437-439.
16. Osawa H, Kawakami M, Fujii M, Kubo N, Iwanaka H, et al. (2001) Helicobacter pylori infection and coronary heart disease in Japanese patients. Cardiology 95: 14-19.
17. Gasbarrini A, Carloni E, Gasbarrini G, Chisholm SA (2004) Helicobacter pylori and extragastric diseases--other Helicobacters. Helicobacter 9 Suppl 1:57-66.
18. Kowalski M, Pawlik M, Konturek JW, Konturek SJ (2006) Helicobacter pylori infection in coronary artery disease. J Physiol Pharmacol 57 Suppl 3:101-111.
19. Clausen P, Feldt-Rasmussen B, Jensen G, Jensen JS (1999) Endothelial haemostatic factors are associated with progression of urinary albumin excretion in clinically healthy subjects: a 4-year prospective study. Clin Sci 97: 37-43.
20. Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, et al. (2002) Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 51: 1157-1165.
21. Ito Y, Azuma T, Ito S, Miyaji H, Hirai M, et al. (1997) Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan. J Clin Microbiol 35: 1710-1714.